Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s disease

Abstract Coumarins are the phytochemicals, which belong to the family of benzopyrone, that display interesting pharmacological properties. Several natural, synthetic and semisynthetic coumarin derivatives have been discovered in decades for their applicability as lead structures as drugs. Coumarin b...

Full description

Bibliographic Details
Main Authors: Samina Khan Yusufzai, Mohammad Shaheen Khan, Othman Sulaiman, Hasnah Osman, Dalily Nabilah Lamjin
Format: Article
Language:English
Published: BMC 2018-12-01
Series:Chemistry Central Journal
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13065-018-0497-z
_version_ 1818365270410919936
author Samina Khan Yusufzai
Mohammad Shaheen Khan
Othman Sulaiman
Hasnah Osman
Dalily Nabilah Lamjin
author_facet Samina Khan Yusufzai
Mohammad Shaheen Khan
Othman Sulaiman
Hasnah Osman
Dalily Nabilah Lamjin
author_sort Samina Khan Yusufzai
collection DOAJ
description Abstract Coumarins are the phytochemicals, which belong to the family of benzopyrone, that display interesting pharmacological properties. Several natural, synthetic and semisynthetic coumarin derivatives have been discovered in decades for their applicability as lead structures as drugs. Coumarin based conjugates have been described as potential AChE, BuChE, MAO and β-amyloid inhibitors. Therefore, the objective of this review is to focus on the construction of these pharmacologically important coumarin analogues with anti-Alzheimer’s activities, highlight their docking studies and structure–activity relationships based on their substitution pattern with respect to the selected positions on the chromen ring by emphasising on the research reports conducted in between year 1968 to 2017.
first_indexed 2024-12-13T22:17:36Z
format Article
id doaj.art-ca072bd9cec047479d7ee4dacde32a3a
institution Directory Open Access Journal
issn 1752-153X
language English
last_indexed 2024-12-13T22:17:36Z
publishDate 2018-12-01
publisher BMC
record_format Article
series Chemistry Central Journal
spelling doaj.art-ca072bd9cec047479d7ee4dacde32a3a2022-12-21T23:29:28ZengBMCChemistry Central Journal1752-153X2018-12-0112115710.1186/s13065-018-0497-zMolecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s diseaseSamina Khan Yusufzai0Mohammad Shaheen Khan1Othman Sulaiman2Hasnah Osman3Dalily Nabilah Lamjin4School of Industrial Technology, Universiti Sains MalaysiaIndustrial Chemistry Programme, Faculty of Science and Natural Resources, Universiti Malaysia SabahSchool of Industrial Technology, Universiti Sains MalaysiaSchool of Chemical Sciences, Universiti Sains MalaysiaIndustrial Chemistry Programme, Faculty of Science and Natural Resources, Universiti Malaysia SabahAbstract Coumarins are the phytochemicals, which belong to the family of benzopyrone, that display interesting pharmacological properties. Several natural, synthetic and semisynthetic coumarin derivatives have been discovered in decades for their applicability as lead structures as drugs. Coumarin based conjugates have been described as potential AChE, BuChE, MAO and β-amyloid inhibitors. Therefore, the objective of this review is to focus on the construction of these pharmacologically important coumarin analogues with anti-Alzheimer’s activities, highlight their docking studies and structure–activity relationships based on their substitution pattern with respect to the selected positions on the chromen ring by emphasising on the research reports conducted in between year 1968 to 2017.http://link.springer.com/article/10.1186/s13065-018-0497-zCoumarinNeurodegenerative disorderAlzheimer’s diseaseAcetylcholinesteraseButyrylcholinesteraseMonoamine oxidase
spellingShingle Samina Khan Yusufzai
Mohammad Shaheen Khan
Othman Sulaiman
Hasnah Osman
Dalily Nabilah Lamjin
Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s disease
Chemistry Central Journal
Coumarin
Neurodegenerative disorder
Alzheimer’s disease
Acetylcholinesterase
Butyrylcholinesterase
Monoamine oxidase
title Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s disease
title_full Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s disease
title_fullStr Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s disease
title_full_unstemmed Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s disease
title_short Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s disease
title_sort molecular docking studies of coumarin hybrids as potential acetylcholinesterase butyrylcholinesterase monoamine oxidase a b and β amyloid inhibitors for alzheimer s disease
topic Coumarin
Neurodegenerative disorder
Alzheimer’s disease
Acetylcholinesterase
Butyrylcholinesterase
Monoamine oxidase
url http://link.springer.com/article/10.1186/s13065-018-0497-z
work_keys_str_mv AT saminakhanyusufzai moleculardockingstudiesofcoumarinhybridsaspotentialacetylcholinesterasebutyrylcholinesterasemonoamineoxidaseabandbamyloidinhibitorsforalzheimersdisease
AT mohammadshaheenkhan moleculardockingstudiesofcoumarinhybridsaspotentialacetylcholinesterasebutyrylcholinesterasemonoamineoxidaseabandbamyloidinhibitorsforalzheimersdisease
AT othmansulaiman moleculardockingstudiesofcoumarinhybridsaspotentialacetylcholinesterasebutyrylcholinesterasemonoamineoxidaseabandbamyloidinhibitorsforalzheimersdisease
AT hasnahosman moleculardockingstudiesofcoumarinhybridsaspotentialacetylcholinesterasebutyrylcholinesterasemonoamineoxidaseabandbamyloidinhibitorsforalzheimersdisease
AT dalilynabilahlamjin moleculardockingstudiesofcoumarinhybridsaspotentialacetylcholinesterasebutyrylcholinesterasemonoamineoxidaseabandbamyloidinhibitorsforalzheimersdisease